Cannell Capital - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 29 filers reported holding TSCAN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Cannell Capital ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$30,799
+35.5%
14,6660.0%0.01%
+20.0%
Q4 2022$22,732
-49.5%
14,6660.0%0.01%
-50.0%
Q3 2022$45,000
+309.1%
14,666
+301.4%
0.01%
+400.0%
Q2 2022$11,0003,6540.00%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DC Funds, LP 630,000$1,981,00027.33%
TANG CAPITAL MANAGEMENT LLC 747,800$2,352,0000.36%
DC Investments Management, LLC 35,563$112,0000.25%
Deer Management Co. LLC 1,245,505$3,917,0000.25%
Alphabet Inc. 1,077,080$3,387,0000.18%
Newtyn Management, LLC 248,611$782,0000.15%
Baker Brothers Advisors 2,784,792$8,758,0000.05%
Marquette Asset Management, LLC 28,895$91,0000.03%
Tekla Capital Management LLC 200,000$629,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 115,000$362,0000.01%
View complete list of TSCAN THERAPEUTICS INC shareholders